ICSASG Breaking News Opdivo Perioperative Regimen Approved in Europe for PD-L1-Positive NSCLC Patients Pathos AI Raises $365M in Series D Financing to Advance AI Oncology Drug Development QurAlis Inks Deals to Advance Precision Medicine for Fragile X Syndrome In Brief This Week: Hemogenyx, Prevencio, Beam, Abeona, Sarepta, Cure Rare Disease OncoHost, Hospital Partners Nab €2.5M Grant for Cancer Treatment Biomarker Development Leucid Bio Begins Phase I Trial of CAR T-Cell Therapy in NKG2DL-Expressing Solid Tumors
